瑞金医院普外科主任郑民华等20名上海市政协委员提案《关于在药品集采背景下如何能够用到疗效好的药物》：高血压糖尿病药物、肠镜泻药麻醉药集采后药效不佳，加大药量也不起效。希望放开国产仿制与进口原研药比例限制，把选择权交给医生；落实不良反应报告制度，及时报告疗效存疑的药物。
国家医保局去函上海医保局，要求其联系瑞金医院郑民华，代表国家局致谢并进一步了解具体品种，责成中选企业回应临床关切，确有质量问题的解除采购协议。
要求上海局举一反三，对于临床反映“集采中选药品降价后存在质量问题”的参照跟进，如存在严重质量问题的报药监。欢迎医务人员做药品价格和质量问题的吹哨人。
（东方网，健识局）
BY 竹新社
A spike in interest rates since the start of the year has accelerated a rotation out of high-growth technology stocks and into value stocks poised to benefit from a reopening of the economy. The Nasdaq has fallen more than 10% over the past month as the Dow has soared to record highs, with a spike in the 10-year US Treasury yield acting as the main catalyst. It recently surged to a cycle high of more than 1.60% after starting the year below 1%. But according to Jim Paulsen, the Leuthold Group's chief investment strategist, rising interest rates do not represent a long-term threat to the stock market. Paulsen expects the 10-year yield to cross 2% by the end of the year. A spike in interest rates and its impact on the stock market depends on the economic backdrop, according to Paulsen. Rising interest rates amid a strengthening economy "may prove no challenge at all for stocks," Paulsen said.
竹新社 from us